Intervention

Iniparib

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions3

Lead sponsors shown1

Clinical trials

3 shown

SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung CancerNCT01086254 · 2010-05-01

Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast CancerNCT01045304 · 2010-02-01

A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast CancerNCT00938652 · 2009-07-01

Common conditions

Breast Cancer1 Breast Cancer, Metastatic1 Non-small Cell Lung Cancer Stage IV1

Leading sponsors

Trial status mix

COMPLETED3

Phase mix

PHASE22

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.